Data wydania decyzji |
Nazwa produktu leczniczego |
Posiadacz pozwolenia na dopuszczenie do obrotu |
Numer wpisu w rejestrze wspólnotowym |
Data notyfikacji |
2.6.2008 |
Xyrem |
UCB Pharma Ltd 208 Bath Road
Slough
Berkshire SL1 3WE
United Kingdom
|
EU/1/05/312/001 |
4.6.2008 |
2.6.2008 |
Dafiro |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/371/001-033 |
4.6.2008 |
2.6.2008 |
Copalia |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/372/001-033 |
4.6.2008 |
3.6.2008 |
Exforge |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/370/001-033 |
5.6.2008 |
3.6.2008 |
Imprida |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/373/001-003 |
5.6.2008 |
4.6.2008 |
Evoltra |
Bioenvision Limited Bassett House
5 Southwell Park Road
Camberley
Surrey GU15 3PU
United Kingdom
Genzyme Europe BV
Gooimeer 10
1411 DD Naarden
Nederland
|
EU/1/06/334/001-004 |
6.6.2008 |
6.6.2008 |
Vaniqa |
Shire Pharmaceutical Contracts Ltd Hampshire International Business Park
Chineham
Basingstoke
Hampshire RG24 8EP
United Kingdom
Laboratorios Almirall S.A.
Ronda General Mitre, no 151
E-08022 Barcelona
|
EU/1/01/173/001-003 |
10.6.2008 11.6.2008 |
10.6.2008 |
Olanzapine Neopharma |
Neopharma Limited 57 High Street
Odiham
Hampshire RG29 1LF
United Kingdom
|
EU/1/07/426/001-011 |
12.6.2008 |
10.6.2008 |
Imprida |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/373/001-033 |
12.6.2008 |
10.6.2008 |
Irbesartan BMS |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/06/375/001-033 |
12.6.2008 |
10.6.2008 |
Exforge |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/370/001-033 |
12.6.2008 |
10.6.2008 |
Copalia |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/372/001-033 |
12.6.2008 |
10.6.2008 |
Aprovel |
Sanofi Pharma Bristol-Myers Squibb SNC
174, avenue de France
F-75013Paris
|
EU/1/97/046/001-039 |
12.6.2008 |
10.6.2008 |
Olanzapine Teva |
Teva Pharma B.V. Computerweg 10
DR Utrecht 3542
Nederland
|
EU/1/07/427/001-057 |
12.6.2008 |
10.6.2008 |
Karvea |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/97/049/001-039 |
12.6.2008 |
10.6.2008 |
Karvezide |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/98/085/001-034 |
12.6.2008 |
10.6.2008 |
CoAprovel |
Sanofi Pharma Bristol-Myers Squibb SNC
174, avenue de France
F-75013 Paris
|
EU/1/98/086/001-034 |
12.6.2008 |
10.6.2008 |
Irbesartan HCT BMS |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/06/369/001-028 |
12.6.2008 |
10.6.2008 |
Irbesartan HCT Winthrop |
Sanofi Pharma Bristol-Myers Squibb SNC
174, avenue de France
F-75013 Paris
|
EU/1/06/377/001-028 |
12.6.2008 |
10.6.2008 |
Dafiro |
Novartis Europharm Limited Wimblehurst Road
Horsham
West Sussex RH12 5AB
United Kingdom
|
EU/1/06/371/001-033 |
12.6.2008 |
11.6.2008 |
Irbesartan Winthrop |
Sanofi Pharma Bristol-Myers Squibb SNC
174, avenue de France
F-75013 Paris
|
EU/1/06/376/001-033 |
13.6.2008 |
12.6.2008 |
Optison |
GE Healthcare AS Nycoveien 1-2
P.O.Box 4220 Nydalen
N-0401 Oslo
|
EU/1/98/065/001-002 |
16.6.2008 |
17.6.2008 |
Xenical |
Roche Registration Limited 6 Falcon Way
Shire Park
Welwyn Garden City AL7 1TW
United Kingdom
|
EU/1/98/071/001-006 |
19.6.2008 |
18.6.2008 |
Insuman - |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main
|
EU/1/97/030/028-139 |
20.6.2008 |
18.6.2008 |
Novomix |
Novo Nordisk A/S Novo Allé
DK-2880 Bagsværd
|
EU/1/00/142/004-005 EU/1/00/142/009-022 |
20.6.2008 |
18.6.2008 |
Insulin Human Winthrop |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main
|
EU/1/06/368/001-057 |
20.6.2008 |
18.6.2008 |
Norvir |
Abbott Laboratories Ltd Queenborough
Kent ME11 5EL
United Kingdom
|
EU/1/96/016/001 EU/1/96/016/003-004 |
20.6.2008 |
18.6.2008 |
Remicade |
Centocor B.V. Einsteinweg 101
2333 CB Leiden
Nederland
|
EU/1/99/116/001-003 |
20.6.2008 |
18.6.2008 |
Atripla |
Bristol-Myers Squibb and Gilead Sciences Limited
Unit 13
Stillorgan Industrial Park
Blackrock Co.
Dublin
Ireland
|
EU/1/07/430/001 |
23.6.2008 |
18.6.2008 |
Tamiflu |
Roche Registration Limited 6 Falcon Way
Shire Park
Welwyn Garden City AL7 1TW
United Kingdom
|
EU/1/02/222/001-004 |
20.6.2008 |
18.6.2008 |
Parareg |
Dompé Biotec S.p.A. Via San Martino, 12
I-20122 Milano
|
EU/1/04/293/001-012 |
20.6.2008 |
18.6.2008 |
Agenerase |
Glaxo Group Ltd Greenford Road
Greenford
Middlesex UB6 0NN
United Kingdom
|
EU/1/00/148/001-004 |
20.6.2008 |
18.6.2008 |
Renagel |
Genzyme Europe B.V. Gooimeer 10
1411 DD Naarden Nederland
|
EU/1/99/123/005-012 |
20.6.2008 |
19.6.2008 |
Twinrix Paediatric |
GlaxoSmithKline Biologicals s.a. rue de l'Institut 89
B-1330Rixensart
|
EU/1/97/029/001-010 |
23.6.2008 |
19.6.2008 |
Rotarix |
GlaxoSmithKline Biologicals s.a. rue de l'Institut 89
B-1330 Rixensart
|
EU/1/05/330/001-004 |
23.6.2008 |
19.6.2008 |
Cholestagel |
Genzyme Europe B.V. Gooimeer 10
1411 DD Naarden
Nederland
|
EU/1/03/268/001-004 |
23.6.2008 |
19.6.2008 |
Plavix |
Sanofi Pharma Bristol-Myers Squibb SNC
174, avenue de France
F-75013Paris
|
EU/1/98/069/001a-007b, 008-010 |
23.6.2008 |
19.6.2008 |
Iscover |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/98/070/001a-007b, 008-010 |
23.6.2008 |
19.6.2008 |
InductOs |
Wyeth Europa Ltd Huntercombe Lane South
Taplow
Maidenhead
Berkshire SL6 0PH
United Kingdom
|
EU/1/02/226/001 |
23.6.2008 |
19.6.2008 |
Paxene |
Norton Healthcare Limited Albert Basin
Royal Docks
London E16 2QJ
United Kingdom
|
EU/1/99/113/001-004 |
24.6.2008 |
19.6.2008 |
Mimpara |
Amgen Europe B.V. Minervum 7061
4817 ZK Breda Nederland
|
EU/1/04/292/001-012 |
23.6.2008 |
19.6.2008 |
TwinrixAdult |
GlaxoSmithKline Biologicals s.a. rue de l'Institut 89
B-1330 Rixensart
|
EU/1/96/020/001-009 |
23.6.2008 |
20.6.2008 |
PEGASYS |
Roche Registration Limited 6 Falcon Way
Shire Park
Welwyn Garden City AL7 1TW
United Kingdom
|
EU/1/02/221/001-010 |
24.6.2008 |
20.6.2008 |
Viracept |
Roche Registration Limited 6 Falcon Way
Shire Park
Welwyn Garden City AL7 1TW
United Kingdom
|
EU/1/97/054/001 EU/1/97/054/004-005 |
24.6.2008 |
20.6.2008 |
Azopt |
Alcon Laboratories (UK) Ltd Pentagon Park
Boundary Way
Hemel Hempstead
Herts HP2 7UD
United Kingdom
|
EU/1/00/129/001-003 |
24.6.2008 |
20.6.2008 |
Tysabri |
Elan Pharma International Ltd Monksland
Athlone
County Westmeath
Ireland
|
EU/1/06/346/001 |
26.6.2008 |
20.6.2008 |
REYATAZ |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/03/267/001-009 |
24.6.2008 |
20.6.2008 |
Evra |
Janssen-Cilag International NV Turnhoutseweg 30
B-2340 Beerse
|
EU/1/02/223/001-003 |
24.6.2008 |
20.6.2008 |
Crixivan |
Merck Sharp & Dohme Ltd Hertford Road Hoddesdon
Hertfordshire EN11 9BU
United Kingdom
|
EU/1/96/024/001-005 EU/1/96/024/007-08
EU/1/96/024/010
|
24.6.2008 |
20.6.2008 |
Apidra |
Sanofi-Aventis Deutschland GmbH Brueningstrasse, 50
D-65926 Frankfurt am Main
|
EU/1/04/285/001-036 |
24.6.2008 |
20.6.2008 |
Prezista |
Janssen-Cilag International NV Turnhoutseweg 30
B-2340 Beerse
|
EU/1/06/380/001 |
24.6.2008 |
20.6.2008 |
ProQuad |
Sanofi Pasteur MSD, SNC 8, rue Jonas Salk
F-69007 Lyon
|
EU/1/05/323/001-013 |
24.6.2008 |
20.6.2008 |
Abilify |
Otsuka Pharmaceutical Europe Ltd Hunton House
Highbridge Business Park
Oxford Road
Uxbridge
Middlesex UB8 1HU
United Kingdom
|
EU/1/04/276/036 |
24.6.2008 |
20.6.2008 |
M-M-RVAXPRO |
Sanofi Pasteur MSD, SNC 8, rue Jonas Salk
F-69007 Lyon
|
EU/1/06/337/001-013 |
24.6.2008 |
20.6.2008 |
Puregon |
Organon N.V. Kloosterstraat 6
Postbus 20 5340 BH Oss
Nederland
|
EU/1/96/008/001-041 |
24.6.2008 |
20.6.2008 |
Kaletra |
Abbott Laboratories Ltd Queenborough
Kent ME11 5EL
United Kingdom
|
EU/1/01/172/001-006 |
24.6.2008 |
20.6.2008 |
Vistide |
Pfizer Enterprises SARL 51, Avenue Kennedy-Rond Point du
Kirchberg
L-1855Luxembourg
|
EU/1/97/037/001- |
24.6.2008 |
20.6.2008 |
Raptiva |
Serono Europe Limited 56, Marsh Wall
London E14 9TP
United Kingdom
|
EU/1/04/291/001-002 |
24.6.2008 |
20.6.2008 |
Prevenar |
Wyeth-LederleVaccinesS.A. Rue du Bosquet15
B-1348 Louvain-La-Neuve
|
EU/1/00/167/001-008 |
24.6.2008 |
20.6.2008 |
Rapilysin |
RocheRegistration Limited 6 Falcon Way
Shire Park
Welwyn Garden City AL7 1TW
United Kingdom
Actavis Group PTC ehf.
Reykjavikurvegi 76-78
IS-220 Hafnarfjordur
|
EU/1/97/033/002 |
24.6.2008 24.6.2008 |
20.6.2008 |
Avonex |
Biogen Idec Ltd 5 Roxborough Way
Foundation Park
Maidenhead
Berkshire SL6 3UD
United Kindgom
|
EU/1/97/033/002-004 |
24.6.2008 |
20.6.2008 |
Vfend |
Pfizer Ltd Ramsgate Road
Sandwich
Kent CT 13 9NJ
United Kingdom
|
EU/1/02/212/001-026 |
24.6.2008 |
20.6.2008 |
Telzir |
Glaxo Group Ltd Greenford Road
Greenford
Middlesex UB6 0NN
United Kingdom
|
EU/1/04/282/001-002 |
24.6.2008 |
23.6.2008 |
Humira |
Abbott Laboratories Ltd Queenborough
Kent ME11 5EL
United Kingdom
|
EU/1/03/256/001-010 |
25.6.2008 |
25.6.2008 |
Optisulin |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main
|
EU/1/00/133/001-007 |
27.6.2008 |
25.6.2008 |
Baraclude |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/06/343/001-007 |
27.6.2008 |
25.6.2008 |
Lantus |
Sanofi-Aventis Deutschland GmbH D-65926 Frankfurt am Main
|
EU/1/00/134/001-037 |
27.6.2008 |
25.6.2008 |
Temodal |
Schering Plough Europe Rue de Stalle 73/Stallestraat 73
B-1180 Bruxelles/B-1180 Brussel
|
EU/1/98/096/001-012 |
27.6.2008 |
25.6.2008 |
Elaprase |
Shire Human Genetic Therapies AB Rinkebyvägen 11 B
S-182 36Danderyd
|
EU/1/06/365/001-003 |
27.6.2008 |
27.6.2008 |
Abseamed |
Medice Arzneimittel Pütter GmbH & Co KG Kuhloweg 37
D-58638 Iserlohn
|
EU/1/07/412/001-020 |
1.7.2008 |
30.6.2008 |
Sprycel |
Bristol-Myers Squibb Pharma EEIG Uxbridge Business Park
Sanderson Road
Uxbridge UB8 1DH
United Kingdom
|
EU/1/06/363/001-009 |
2.7.2008 |